GlaxoSmithKline (NYSE:GSK) plans to sell its 5.7% stake in Hindustan Unilever Ltd. (NYSE:UL) via a series of block trades totaling $3.7B.
The company received the equity this week as part
of the payment for a recently completed sale of a portfolio of assets to
Unilever that included health food drink brands in India and Bangladesh
for $3.6B in cash plus the Hindustan stake.
The precise timing of the sales has not been disclosed.
https://seekingalpha.com/news/3565968-glaxo-to-divest-3_7b-stake-in-unilever-india-unit
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.